AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

General Biologicals Corporation

TWD 8.97 -$3.88 (-30.19%)
TWO · 16 Sep 2026 05:59 UTC
Previous Close
TWD 8.97
Day Range
TWD 8.92TWD 9.15
Year Range
TWD 3.5TWD 17.75
Market Cap
630.81M
AVG Volume
241.47K
Trailing/Forward PE
1.01/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Taipei ExchangeTW
Revenue (TWD)
0100M200M300M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Revenue (TWD) by quarter
PeriodRevenue (TWD)
26 Q2155.22M
25 Q4105.01M
25 Q2110.73M
24 Q4140.65M
24 Q2111.28M
23 Q4131.13M
23 Q2133.7M
22 Q4143.99M
22 Q2226.47M
Net Income (TWD)
-200M0200M400M600M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Net Income (TWD) by quarter
PeriodNet Income (TWD)
26 Q2-75.65M
25 Q4594.63M
25 Q2-128.79M
24 Q4-114.8M
24 Q2-106.02M
23 Q4-103.29M
23 Q2-95.55M
22 Q4-67.11M
22 Q213.91M
Operating Income (TWD)
-150M-100M-50M050M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Operating Income (TWD) by quarter
PeriodOperating Income (TWD)
26 Q2-61.55M
25 Q4-109.38M
25 Q2-108.99M
24 Q4-119.06M
24 Q2-96.72M
23 Q4-82.19M
23 Q2-87.75M
22 Q4-62.79M
22 Q221.92M
EBITDA (TWD)
-200M0200M400M600M800M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO EBITDA (TWD) by quarter
PeriodEBITDA (TWD)
26 Q2-12.45M
25 Q4678.77M
25 Q2-74.47M
24 Q4-108.37M
24 Q2-78.14M
23 Q4-70.3M
23 Q2-80.07M
22 Q4-54.28M
22 Q262.27M
Cash Flows (TWD)
-1.5B-1B-500M0500M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Cash Flows (TWD) by quarter
PeriodCash Flows (TWD)
26 Q2-55.19M
25 Q4-27.35M
25 Q2-275.46M
24 Q4-378.48M
24 Q2-1.28B
23 Q4-54.44M
23 Q2-143.89M
22 Q4-175.54M
22 Q2151.94M
EPS (TWD)
-5051022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO EPS (TWD) by quarter
PeriodEPS (TWD)
26 Q2-1.08
25 Q49.95
25 Q2-2.16
24 Q4-1.92
24 Q2-1.78
23 Q4-1.72
23 Q2-1.6
22 Q4-1.12
22 Q20.23
Expenses (TWD)
-500M0500M1B1.5BR&DSG&ACapex22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Expenses (TWD) by quarter
PeriodExpenses (TWD)
26 Q2111.96M
25 Q4150.85M
25 Q2296.71M
24 Q4405.62M
24 Q21.36B
23 Q4257.03M
23 Q2403.5M
22 Q4276.51M
22 Q2188.52M
Cash & Debt (TWD)
01B2B3BCashLong Term DebtShort Term Debt22 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Cash & Debt (TWD) by quarter
PeriodCash & Debt (TWD)
26 Q2606.76M
25 Q4634.75M
25 Q2195.76M
24 Q4251.65M
24 Q2216.66M
23 Q4217.12M
23 Q2206.19M
22 Q4351.08M
Debt ratios
-10-50523 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Debt ratios by quarter
PeriodDebt ratios
26 Q23.98
25 Q44.46
25 Q2-7
24 Q4-6.11
24 Q2-5.95
23 Q4-2.33
Margins
-20%0%20%40%60%22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Margins by quarter
PeriodMargins
26 Q228.18%
25 Q442.78%
25 Q213.27%
24 Q4-4.29%
24 Q212.19%
23 Q430.63%
23 Q216.86%
22 Q427.4%
22 Q258.46%
Return on Capital
-100%-50%0%50%100%22 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Return on Capital by quarter
PeriodReturn on Capital
26 Q2-9.48%
25 Q468.16%
25 Q2-82.08%
24 Q4-40.07%
24 Q2-26.35%
23 Q4-20.8%
23 Q2-15.98%
22 Q4-9.68%
Shares Outstanding
020M40M60M80M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Shares Outstanding by quarter
PeriodShares Outstanding
26 Q270.31M
25 Q459.83M
25 Q259.83M
24 Q459.79M
24 Q259.9M
23 Q459.83M
23 Q259.72M
22 Q459.83M
22 Q259.83M
Book Value Per Share (TWD)
05101522 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Book Value Per Share (TWD) by quarter
PeriodBook Value Per Share (TWD)
26 Q211.35
25 Q414.58
25 Q22.62
24 Q44.79
24 Q26.72
23 Q48.3
23 Q210.01
22 Q411.58
Total Assets (TWD)
02B4B6B22 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
4117.TWO Total Assets (TWD) by quarter
PeriodTotal Assets (TWD)
26 Q24.84B
25 Q44.87B
25 Q23.54B
24 Q43.41B
24 Q23.16B
23 Q42.54B
23 Q21.85B
22 Q41.55B
PE Ratio
1234med 2.34May 26Jun 26Jun 26Jul 26Aug 26Aug 26Sep 26
4117.TWO PE Ratio by quarter
PeriodPE Ratio
Sep 262.19
Sep 262.21
Sep 262.22
Aug 262.24
Aug 262.34
Aug 262.45
Aug 262.51
Jul 262.47
Jul 262.53
Jul 262.61
Jul 262.56
Jul 262.47
Jun 262.73
Jun 263.1
Jun 262.92
Jun 261.05
May 261.05
May 261.05
May 261.05
Apr 261.05
Apr 261.05
Free Cash Flow Yield
-800%-600%-400%-200%0%med -206.09%Nov 24Mar 25Jun 25Oct 25Jan 26Jun 26Sep 26
4117.TWO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-365.98%
Sep 26-362.74%
Sep 26-360.75%
Aug 26-357.99%
Aug 26-341.96%
Aug 26-326.65%
Aug 26-318.72%
Jul 26-325.03%
Jul 26-317.18%
Jul 26-306.8%
Jul 26-312.65%
Jul 26-325.03%
Jun 26-293.11%
Jun 26-258.49%
Jun 26-274.71%
Jun 26-763.44%
May 26-763.44%
May 26-763.44%
May 26-763.44%
Apr 26-763.44%
Apr 26-763.44%
Mar 26-773.97%
Mar 26-773.97%
Mar 26-773.97%
Mar 26-298.48%
Feb 26-291.94%
Feb 26-273.92%
Feb 26-270.58%
Jan 26-266.25%
Jan 26-276.19%
Jan 26-270.58%
Jan 26-262.05%
Jan 26-265.19%
Dec 25-256.01%
Dec 25-260.01%
Dec 25-260.01%
Dec 25-272.79%
Nov 25-273.92%
Nov 25-280.85%
Nov 25-272.79%
Nov 25-260.01%
Oct 25-217.52%
Oct 25-209.31%
Oct 25-221.87%
Oct 25-214.02%
Oct 25-212.66%
Sep 25-196.82%
Sep 25-194.97%
Sep 25-188.47%
Sep 25-199.09%
Aug 25-196.08%
Aug 25-201.02%
Aug 25-202.86%
Aug 25-188.47%
Aug 25-195.58%
Jul 25-184.56%
Jul 25-199.35%
Jul 25-194.36%
Jul 25-194.36%
Jun 25-170.87%
Jun 25-184.01%
Jun 25-163.24%
Jun 25-136.69%
May 25-135.5%
May 25-148.79%
May 25-177.2%
May 25-213%
May 25-200.63%
Apr 25-215.21%
Apr 25-219.77%
Apr 25-223.73%
Apr 25-184.56%
Mar 25-169.15%
Mar 25-158.03%
Mar 25-151.54%
Mar 25-148.69%
Feb 25-141.1%
Feb 25-147.5%
Feb 25-149.49%
Feb 25-144.04%
Jan 25-147.89%
Jan 25-141.46%
Jan 25-125.14%
Jan 25-134.58%
Dec 24-131.07%
Dec 24-159.4%
Dec 24-158.03%
Dec 24-160.32%
Nov 24-165.6%
Nov 24-156.69%
Nov 24-154.93%
Nov 24-149.49%
Nov 24-151.54%
Oct 24-151.12%
Oct 24-148.69%
Oct 24-146.33%
Oct 24-144.04%
Sep 24-19.32%
Sep 24-19.52%
Sep 24-19.22%
Price to Sales
0123med 1.81Nov 24Mar 25Jun 25Oct 25Jan 26Jun 26Sep 26
4117.TWO Price to Sales by quarter
PeriodPrice to Sales
Sep 261.15
Sep 261.16
Sep 261.16
Aug 261.17
Aug 261.23
Aug 261.29
Aug 261.32
Jul 261.29
Jul 261.32
Jul 261.37
Jul 261.34
Jul 261.29
Jun 261.43
Jun 261.62
Jun 261.53
Jun 260.55
May 260.55
May 260.55
May 260.55
Apr 260.55
Apr 260.55
Mar 260.52
Mar 260.52
Mar 260.52
Mar 261.35
Feb 261.38
Feb 261.47
Feb 261.49
Jan 261.51
Jan 261.46
Jan 261.49
Jan 261.54
Jan 261.52
Dec 251.58
Dec 251.55
Dec 251.55
Dec 251.48
Nov 251.47
Nov 251.44
Nov 251.48
Nov 251.55
Oct 251.85
Oct 251.93
Oct 251.82
Oct 251.88
Oct 251.9
Sep 251.83
Sep 251.85
Sep 251.91
Sep 251.81
Aug 251.84
Aug 251.79
Aug 251.77
Aug 251.91
Aug 251.84
Jul 251.95
Jul 251.81
Jul 251.85
Jul 251.85
Jun 252.11
Jun 251.96
Jun 252.2
Jun 252.63
May 252.66
May 252.42
May 252.03
May 251.69
May 251.79
Apr 251.67
Apr 251.64
Apr 251.61
Apr 251.95
Mar 251.88
Mar 252.02
Mar 252.1
Mar 252.14
Feb 252.26
Feb 252.16
Feb 252.13
Feb 252.21
Jan 252.15
Jan 252.25
Jan 252.55
Jan 252.37
Dec 242.43
Dec 242
Dec 242.02
Dec 241.99
Nov 241.92
Nov 242.03
Nov 242.06
Nov 242.13
Nov 242.1
Oct 242.11
Oct 242.14
Oct 242.18
Oct 242.21
Sep 241.81
Sep 241.79
Sep 241.82
EV/EBITDA
55.566.5med 5.83May 26Jun 26Jun 26Jul 26Aug 26Aug 26Sep 26
4117.TWO EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 265.74
Sep 265.75
Sep 265.76
Aug 265.77
Aug 265.83
Aug 265.89
Aug 265.93
Jul 265.9
Jul 265.94
Jul 265.99
Jul 265.96
Jul 265.9
Jun 266.06
Jun 266.27
Jun 266.17
Jun 265.07
May 265.07
May 265.07
May 265.07
Apr 265.07
Apr 265.07
Price/Operating Cashflow
051015med 5.76Jun 24Aug 24Nov 24Feb 25Apr 25Jul 25Sep 25
4117.TWO Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 258.62
Sep 258.7
Sep 259
Sep 258.52
Aug 258.65
Aug 258.44
Aug 258.37
Aug 259
Aug 258.68
Jul 259.19
Jul 258.51
Jul 258.73
Jul 258.73
Jun 259.93
Jun 259.22
Jun 2510.4
Jun 2512.41
May 2512.52
May 2511.4
May 259.58
May 257.97
May 258.46
Apr 257.89
Apr 257.72
Apr 257.59
Apr 259.19
Mar 255.09
Mar 255.45
Mar 255.69
Mar 255.8
Feb 256.11
Feb 255.84
Feb 255.76
Feb 255.98
Jan 255.83
Jan 256.09
Jan 256.89
Jan 256.4
Dec 246.57
Dec 245.41
Dec 245.45
Dec 245.37
Nov 245.2
Nov 245.5
Nov 245.56
Nov 245.76
Nov 245.69
Oct 245.7
Oct 245.8
Oct 245.89
Oct 245.98
Sep 242.55
Sep 242.52
Sep 242.56
Sep 242.56
Aug 242.62
Aug 242.63
Aug 242.66
Aug 242.69
Aug 242.73
Jul 242.77
Jul 243.03
Jul 242.81
Jul 242.95
Jun 243.01
Jun 242.87
Jun 242.87
Jun 242.89
May 242.74
May 242.75
May 242.94
May 242.64
May 242.72
Apr 242.81
Apr 242.77
Apr 242.87
Apr 242.88
Price to Book
02468med 2.94Nov 24Mar 25Jun 25Oct 25Jan 26Jun 26Sep 26
4117.TWO Price to Book by quarter
PeriodPrice to Book
Sep 260.62
Sep 260.62
Sep 260.62
Aug 260.63
Aug 260.66
Aug 260.69
Aug 260.71
Jul 260.69
Jul 260.71
Jul 260.73
Jul 260.72
Jul 260.69
Jun 260.77
Jun 260.87
Jun 260.82
Jun 260.29
May 260.29
May 260.29
May 260.29
Apr 260.29
Apr 260.29
Mar 261.64
Mar 261.64
Mar 261.64
Mar 264.25
Feb 264.35
Feb 264.63
Feb 264.69
Jan 264.77
Jan 264.59
Jan 264.69
Jan 264.84
Jan 264.79
Dec 254.96
Dec 254.88
Dec 254.88
Dec 254.65
Nov 254.63
Nov 254.52
Nov 254.65
Nov 254.88
Oct 255.83
Oct 256.06
Oct 255.72
Oct 255.93
Oct 255.97
Sep 253.3
Sep 253.33
Sep 253.44
Sep 253.26
Aug 253.31
Aug 253.23
Aug 253.2
Aug 253.44
Aug 253.32
Jul 253.52
Jul 253.26
Jul 253.34
Jul 253.34
Jun 253.8
Jun 253.53
Jun 253.98
Jun 254.75
May 254.79
May 254.36
May 253.66
May 253.05
May 253.24
Apr 253.02
Apr 252.95
Apr 252.9
Apr 253.52
Mar 252.43
Mar 252.6
Mar 252.72
Mar 252.77
Feb 252.92
Feb 252.79
Feb 252.75
Feb 252.86
Jan 252.78
Jan 252.91
Jan 253.29
Jan 253.06
Dec 243.14
Dec 242.58
Dec 242.6
Dec 242.57
Nov 242.49
Nov 242.63
Nov 242.66
Nov 242.75
Nov 242.72
Oct 242.72
Oct 242.77
Oct 242.81
Oct 242.86
Sep 242.31
Sep 242.29
Sep 242.32
General Biologicals Corporation
4117.TWO
Stockpicker

Video analysis: 4117.TWO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.